TYRATyra Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 22925
Ticker: TYRA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-09-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TYRA

Detail

Enriched 2026-08-14 20:47

Market cap: $1,509,826,556.7
Shares outstanding (class): 59,676,939
Shares outstanding (weighted): 59,676,939
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 87
Location: CARLSBAD, CA
Homepage: https://www.tyra.bio
Description: Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Market cap and share counts drift.

Funds holding this security

87 funds · 87 positions · $224.19M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$32.03M	0.00%	836,172 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$25.10M	0.34%	655,457 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$24.38M	0.03%	636,602 NS	FIGI
VIP Growth Portfolio Variable Insurance Products Fund	—	$19.84M	0.19%	518,000 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$13.45M	0.26%	351,278 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$11.76M	0.11%	307,082 NS	FIGI
Fidelity Growth Discovery Fund Fidelity Hastings Street Trust	—	$10.75M	0.19%	280,800 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$10.44M	0.13%	272,474 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$10.05M	0.01%	262,408 NS	FIGI
Fidelity Fund Fidelity Hastings Street Trust	—	$9.52M	0.11%	248,500 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$8.50M	0.07%	222,011 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$8.48M	0.07%	221,482 NS	FIGI
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$7.82M	0.26%	204,289 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$6.14M	0.07%	160,400 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$2.50M	0.21%	65,304 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTYRA
FIGI_COMPOSITEBBG00RCQD9D1
FIGI_SHARE_CLASSBBG00RCQD9F9
CIK0001863127
ISINUS90240B1061
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a biopharmaceutical company classified under SIC 2834, indicating pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.